Платформа быстрого доступа DELFIA® Xpress

Speed and flexibility of random access

ОБЗОР

Aneuploidy and pre-eclampsia screening

Платформа быстрого доступа DELFIA® Xpress для пренатального скрининга обеспечивает полную гибкость системы с быстрым доступом, с широким диапазоном наборов для пренатального скрининга и скрининга на преэклампсию — с надежными результатами, которым можно доверять. The platfom offers a variety of benefits critical for operational efficiency, and with a wide range of available kits it supports different strategies in aneuploidy and pre-eclampsia screening.

Instrument

Streamlined workflows for operational efficiency

shutterstock_267649127_PKI

Simplicity and Ease of Use

The simplicity and ease of use of a new generation instrument with up-to-date software design

Barcode scanning

Security

The security associated with barcoded reagents and samples to ensure positive identification

shutterstock_707493328

Ideal Solution

An ideal solution for delivering OSCAR (one stop clinic for assessment of risk) services

Close up of lab assistant in uniform, with mask and rubber gloves holding test tube with blood sample while sitting on chair and typing on laptop. Selective focus on test tubes.

Streamlined Workflow

Designed to streamline workflows in laboratories and clinics providing prenatal screening services

DELFIA® chemistry

Clinically validated assays

PerkinElmer maternal serum biochemistry assays are based on the robust and sensitive DELFIA® chemistry with measurement by time-resolved fluorometry.

  • Assays optimized for prenatal risk assessment
  • All screening assays are CE-IVD marked, aneuploidy screening
  • Assays under Annex 2, List B (Medium risk products)
  • Extensive internal QC
  • Low lot-to-lot variation
Kits

Complete management solution for your laboratory

ПРОГРАММНОЕ ОБЕСПЕЧЕНИЕ
Analyze at scale
ПРОГРАММНОЕ ОБЕСПЕЧЕНИЕ

LifeCycle™ software

As a world leader in prenatal screening, PerkinElmer understands the needs of the screening laboratory and its users. The industry leading LifeCycle™ software for prenatal screening is much more than just a risk calculator. It is a complete solution for handling the laboratory workflow from receipt of sample to reporting of results. LifeCycle™ software is designed to integrate seamlessly with PerkinElmer instruments and kits.

Laboratory Equipment no matter your size or sophistication

More Prenatal Screening Instruments

AutoDELFIA® immunoassay system

AutoDELFIA® immunoassay system

AutoDELFIA® immunoassay system for prenatal & neonatal screening with fully automated batch-loading
VICTOR2™ D Fluorometer

VICTOR2™ D Fluorometer

Fluorometer designed for clinical use with all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence.
Articles & Resources

Articles & Resources

A Case of SMA with Pompe Disease in India
Newborn
09 Июн 2021

A Case of SMA with Pompe Disease in India

In a recent case in India, a child was diagnosed with simultaneous Pompe disease and spinal muscular atrophy (SMA). See Dr. Priyanshu Mathur’s presentation to learn more about the rare case and how the child was identified for treatment.
Newborn screening for LSDs — a pilot study from Brazil
Newborn
09 Июн 2021

Newborn screening for LSDs — a pilot study from Brazil

Early diagnosis of lysosomal storage disorders is essential for better patient outcomes. In her presentation, Dr. Francyne Kubaski of the Medical Genetics Service of Brazil shares the learnings from an LSD newborn screening pilot study using tandem mass spectrometry. The study was conducted using PerkinElmer’s NeoLSD ™ MSMS kit, which enables screening of up to six lysosomal storage disorders from a single blood spot punch. See the video to learn more.
Genomic sequencing in newborns – yes or no?
Newborn
09 Июн 2021

Genomic sequencing in newborns – yes or no?

It’s technically possible to produce high-quality genomic sequencing data from blood spot cards used in newborn screening. However, there are cost considerations, ethical issues as well as limitations in infrastructure and human resources to delivering genomic sequencing at scale. What additional value would genomic sequencing bring to newborn screening? For fresh insights, see the presentation by Professor John Christodoulou of the University of Melbourne Department of Paediatrics.
shutterstock_1689772501 1
Information about industry events, new research papers and upcoming webinars

Stay up to date on what is happening around prenatal care

Join our email list for more information about screening and the importance of early detection. Have the latest news delivered to your inbox.

GET IN TOUCH

Take the next step

Speak with a sales person

Talk to one of our product experts about the right solutions for you.

Contact us today

View more resources

Explore our articles and resources section for the latest information

Learn More

Read the lastest news

Sign up for our newsletter to find out about the latest news from PerkinElmer and the industry

Learn More

Продукты могут быть не лицензированы в соответствии с законодательством других стран, в частности, США Уточните это у своего местного представителя.